APP and Alzheimer disease: To circumvent such problems, we have developed a new genetic model of AD based on a second-generation APP knock-in mouse that avoids artifacts associated with transgenic overexpression and has been widely used to determine how Aβ pathology alters brain function (Saito et al., 2014; Sasaguri et al., 2017).